SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 73 filers reported holding SIERRA ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,279,000 | -24.5% | 3,274,953 | +8.3% | 0.14% | -7.8% |
| Q2 2019 | $1,693,000 | -57.2% | 3,023,559 | +30.7% | 0.15% | -57.1% |
| Q1 2019 | $3,956,000 | +37.9% | 2,313,159 | +6.4% | 0.36% | +106.3% |
| Q4 2018 | $2,869,000 | -6.2% | 2,173,620 | +20.8% | 0.17% | -12.6% |
| Q3 2018 | $3,060,000 | -42.6% | 1,800,000 | 0.0% | 0.20% | -44.7% |
| Q2 2018 | $5,328,000 | +48.0% | 1,800,000 | +3.5% | 0.36% | +13.2% |
| Q1 2018 | $3,600,000 | +4.7% | 1,739,074 | +88.7% | 0.32% | +9.7% |
| Q4 2017 | $3,438,000 | – | 921,774 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $10,708,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $6,627,000 | 1.82% |
| Prosight Management, LP | 2,553,943 | $3,371,000 | 1.74% |
| Abingworth LLP | 1,444,445 | $1,892,000 | 1.72% |
| Broadfin Capital, LLC | 4,880,327 | $6,442,000 | 0.85% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $4,869,000 | 0.65% |
| Vivo Capital, LLC | 2,438,270 | $3,219,000 | 0.41% |
| PA Capital LLC | 138,752 | $183,000 | 0.19% |
| 683 Capital Management, LLC | 2,173,620 | $2,869,000 | 0.17% |
| ARMISTICE CAPITAL, LLC | 1,600,000 | $2,112,000 | 0.16% |